Smith+Nephew
British multinational medical technology company focused on orthopaedics, sports medicine, ear, nose and throat surgery, and advanced wound management.
Last updated October 25, 2026
AI crawler reads
3requests
1companies- Anthropic3
- Profile
- 2
- Controversies
- 1
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Smith & Nephew plc is a British multinational medical technology company whose products are used in orthopaedic reconstruction, trauma and extremities, sports medicine, ear, nose and throat surgery, and advanced wound management. Founded in Kingston upon Hull in 1856 as a dispensing-chemist business, the company initially built its reputation through medical supplies, including cod-liver oil and later surgical dressings. Its wartime dressing contracts during the First World War accelerated its industrial growth and expanded its customer base across military and humanitarian organizations. Over the twentieth century, Smith & Nephew evolved from a textile and dressing supplier into a diversified healthcare manufacturer. It developed or marketed products such as plaster bandages, adhesive dressings, polyurethane wound coverings and other materials used in clinical and consumer healthcare. The company was admitted to the London Stock Exchange in 1937. Post-war diversification included cosmetics, syringes, needles and pharmaceuticals, although the business eventually concentrated more heavily on medical products as competition increased in consumer and pharmaceutical markets. From the 1980s onward, acquisitions helped establish Smith & Nephew as an international orthopaedics and surgical-technology company. The purchase of Richards Medical Company expanded its presence in the United States, while later acquisitions added hip resurfacing, trauma, wound-care biologics, sports-medicine and computer-assisted-surgery capabilities. During the late 1990s and early 2000s, management reorganized the company around wound management, endoscopy and orthopaedics, divesting several long-standing consumer brands and emphasizing higher-value clinical technologies. The company currently operates through three principal global business areas: advanced wound management; sports medicine and ENT; and orthopaedics. Its portfolio includes wound dressings and negative-pressure wound therapy, arthroscopy equipment, surgical repair products, joint-replacement systems, trauma implants, extremity devices and technologies supporting robotic or computer-assisted procedures. Representative product families include PICO negative-pressure wound therapy, JOURNEY knee systems and TRIGEN intramedullary nail systems. Smith & Nephew sells products internationally and remains listed in London, where it has been a constituent of the FTSE 100 Index. Its corporate history also includes regulatory and compliance matters, notably a 2012 settlement involving alleged improper payments by subsidiaries to government-employed doctors in Greece. In recent years the company has continued investing in surgical robotics, digital assistance, extremity orthopaedics and manufacturing infrastructure. Although historically associated with Hull, it has pursued a revised relocation and redevelopment plan involving facilities at Melton while retaining some operational activity at the former Hull base.
History
Smith+Nephew began in 1856 with Thomas James Smith’s pharmacy in Hull, England. The business developed from pharmacy and medical supplies into the manufacture and distribution of surgical dressings and other healthcare products. Its early association with wound care became a durable foundation for the later multinational company. During the twentieth century, Smith+Nephew broadened its activities beyond dressings and pharmaceuticals. It entered medical equipment and surgical technologies, building capabilities in orthopaedics and wound management. The company’s growth increasingly came from specialized products used by healthcare professionals rather than from conventional retail healthcare goods. In the modern period, Smith+Nephew organized its activities around three principal franchises: Orthopaedics, Sports Medicine and Advanced Wound Management. Orthopaedics covers joint replacement, extremity reconstruction and technology-assisted surgery. Sports Medicine focuses on minimally invasive repair and reconstruction of joints and soft tissue. Advanced Wound Management includes dressings, negative-pressure therapy and pressure-injury prevention or monitoring solutions. Acquisitions have been an important part of the company’s development. In 2014, Smith+Nephew acquired ArthroCare, a transaction that materially expanded its sports-medicine capabilities. In 2017, it acquired Rotation Medical and its tissue-regeneration technology, later associated with the REGENETEN Bioinductive Implant. In 2019, the company acquired Osiris Therapeutics, a regenerative-medicine business, and Leaf Healthcare, whose monitoring technology supported pressure-injury prevention. In 2021, it completed the acquisition of Integra LifeSciences’ Extremity Orthopaedics business, adding shoulder and other extremity products. The company has also pursued cartilage-repair and biologic technologies, including the acquisition of CartiHeal. These moves reflect a strategy of combining established surgical franchises with newer regenerative, digital and biologic technologies. The business continues to sell through professional healthcare channels in international markets, with products subject to medical-device regulation and hospital procurement requirements. Smith+Nephew’s contemporary identity is expressed through the “Life Unlimited” purpose. Its communications emphasize restoring movement, physical function and self-belief, while its professional marketing relies heavily on clinical studies, surgeon education, medical congresses, product demonstrations and health-economic evidence. Campaign work has promoted ALLEVYN dressings, PICO negative-pressure therapy and the LEAF monitoring system through digital media and professional audiences. In 2024, Smith+Nephew entered a multiyear marketing partnership with UFC, becoming the organization’s first preferred sports-medicine technology partner. In January 2026, according to the supplied company announcement and trade-press references, it completed the acquisition of Integrity Orthopaedics for an initial cash payment of $225 million plus potential performance-based consideration of up to $225 million over five years. The transaction added Tendon Seam, a rotator-cuff repair system, to the company’s shoulder-repair portfolio. Because the requested name does not correspond to a clearly separate legal or encyclopedic entity, this dossier treats Smith+Nephew plc and its principal medical-technology brand as the subject.
- 2026
Integrity Orthopaedics acquisition completed
[3]Smith+Nephew completed its acquisition of Integrity Orthopaedics and the Tendon Seam rotator-cuff repair system.
- 2024
UFC sports-medicine partnership
[4]Smith+Nephew became UFC’s preferred sports-medicine technology partner under a multiyear marketing agreement.
- 2021
Extremity Orthopaedics acquisition
[2]The acquisition of Integra’s Extremity Orthopaedics business expanded Smith+Nephew’s shoulder and extremity offering.
- 2019
Expansion into regenerative medicine and patient monitoring
[1]Smith+Nephew completed acquisitions of Osiris Therapeutics and Leaf Healthcare.
- 2017
Acquisition of Rotation Medical
[7]The company acquired Rotation Medical and its tissue-regeneration technology for rotator-cuff repair.
- 2014
Acquisition of ArthroCare
[6]Smith+Nephew acquired ArthroCare, strengthening its sports-medicine and surgical-technology portfolio.
- 1856
Business founded in Hull
[6]Thomas James Smith established the pharmacy business that became the foundation of Smith+Nephew.
Products and positioning
An innovation-led global medical-technology company positioned around restoring physical function and confidence through clinically supported solutions in orthopaedics, sports medicine and wound management.
Digital and robotic-assisted orthopaedics
CORI Surgical System
The CORI Surgical System is a technology platform for digitally assisted orthopaedic procedures, particularly knee replacement. It is positioned around helping surgeons plan and execute procedures with computer-assisted tools and patient-specific information.
Sports medicine and tissue regeneration · 2014
REGENETEN Bioinductive Implant
REGENETEN is a bioinductive implant used in rotator-cuff repair procedures. It is intended to support biological tissue healing and complements conventional surgical repair techniques within Smith+Nephew’s shoulder sports-medicine portfolio.
Advanced wound management
PICO Single Use Negative Pressure Wound Therapy
PICO is a portable, single-use negative-pressure wound-therapy system designed for use outside traditional inpatient settings as well as in clinical care. Marketing emphasizes portability and the possibility of supporting earlier discharge while wound treatment continues at home.
Advanced wound management
ALLEVYN Wound Dressings
ALLEVYN is a family of advanced foam wound dressings. The range is marketed for wound exudate management and reduced dressing-change burden, with ALLEVYN LIFE receiving dedicated professional and digital campaigns.
Patient monitoring
LEAF Patient Monitoring System
LEAF is a patient-monitoring system acquired from Leaf Healthcare. It monitors patient orientation and activity to help clinicians personalize and confirm turning protocols for people at risk of pressure injuries.
Rotator-cuff repair
Tendon Seam
Tendon Seam is a rotator-cuff repair system developed by Integrity Orthopaedics and added to Smith+Nephew’s portfolio through the 2026 acquisition. The system is described as using a biomechanical repair approach intended to improve repair stability and reduce re-tear risk.
Controversies
2020
Smith & Nephew announces recalls of medical devices in China
Smith & Nephew entities announced recalls in China of knee and hip surgery instruments and endoscopic hand instruments. The recalls were attributed to labeling or packaging errors. A separate recall of hip instruments cited a design issue that could potentially cause a guide to break.
2017
Mölnlycke litigation over ALLEVYN LIFE claims
Mölnlycke alleged that Smith+Nephew’s advertising and promotional materials made misleading, unsubstantiated or improperly comparative claims about ALLEVYN LIFE dressings and pressure-ulcer prevention. The supplied material describes allegations in a lawsuit, not a confirmed regulatory or judicial finding.
Marketing campaigns
- 2024UFC Preferred Sports Medicine Technology Partnership
International
Smith+Nephew partnered with UFC to activate its brand around selected events and present its sports-medicine technologies to an international sports audience.
- Time to Change
United States
A digital campaign for ALLEVYN LIFE used the idea of time and the dressing’s distinctive shape to communicate the potential convenience of longer wear and fewer dressing changes to nursing audiences.
- Get Them There Sooner
United States
A digital campaign promoted the PICO system to orthopaedic surgeons and obstetrics and gynecology professionals by presenting discharge and recovery as milestones in the patient journey.
- LEAF Patient Monitoring Digital Campaign
United States
A digital lead-generation campaign presented the LEAF system as a tool for personalized turning protocols and pressure-injury prevention.
Outcome. The agency case study reported that the campaign generated twice the expected number of leads.
Brand decisions
2026
Acquire Integrity OrthopaedicsM&ABackground
Smith+Nephew sought to strengthen its shoulder-repair and sports-medicine portfolio with a technology addressing rotator-cuff repair.
Action taken
The company completed the acquisition of Integrity Orthopaedics and its Tendon Seam system.
Aftermath
The transaction combined Tendon Seam with the REGENETEN Bioinductive Implant and other shoulder technologies.
Consideration. Initial cash payment of US$225 million plus potential performance-based payments of up to US$225 million (2026 transaction)
2021
Acquire Integra Extremity OrthopaedicsM&ABackground
The company targeted growth in extremity reconstruction and sought a stronger shoulder and upper- and lower-extremity product portfolio.
Action taken
Smith+Nephew acquired the Extremity Orthopaedics business of Integra LifeSciences.
Aftermath
The transaction added products, a specialized sales channel and a shoulder-replacement pipeline.
Purchase price. US$240 million (2021 acquisition)
Recent events
Reported
Smith+Nephew announced the India launch of Real Intelligence and the CORI Surgical System[11]
Smith+Nephew announced the launch in India of its Real Intelligence suite of enabling technology solutions, including the CORI Surgical System.
Reported
Smith & Nephew completes acquisition of extremity orthopedics business[12]
Smith & Nephew completed its $240 million acquisition of Integra LifeSciences' extremity orthopedics business unit.
Reported
Smith & Nephew announces recalls of medical devices in China[10]
Smith & Nephew entities announced recalls in China of knee and hip surgery instruments and endoscopic hand instruments over labeling or packaging errors; a separate hip instrument recall cited a design issue that could potentially cause a guide to break.
Reported
Fiagon partners with Smith+Nephew for Asia Pacific distribution[13]
Fiagon announced a distribution partnership with Smith+Nephew for Fiagon’s ENT surgical navigation portfolio in the Asia Pacific ASEAN region, covering China, the Indian subcontinent, Australia, New Zealand and other ASEAN markets.
Sources13 sources
- 1Smith+Nephew completes acquisition of Leaf Healthcaresmith-nephew.com
- 2Smith+Nephew completes Extremity Orthopaedics acquisitionsmith-nephew.com
- 3Smith+Nephew completes acquisition of Integrity Orthopaedicssmith-nephew.com
- 4UFC and Smith+Nephew announce multiyear marketing partnershipufc.com
- 5False-advertising allegations concerning ALLEVYN LIFEmarkets.businessinsider.com
- 6Business founded in Hullmergr.com
- 7Acquisition of Rotation Medicalmassdevice.com
- 8Time to Changeredsixmedia.com
- 9LEAF Patient Monitoring Digital Campaignbalcomagency.com
- 10Smith & Nephew announces recalls of medical devices in Chinafinance.sina.com.cn
- 11Smith+Nephew宣布Real Intelligence及CORI手术系统在印度推出prnewswire.com
- 12Smith & Nephew完成四肢骨科业务收购healio.com
- 13Fiagon 与 Smith+Nephew 合作在亚太地区分销产品prnewswire.com
Cite this profile: Cite the canonical profile. /brand-wiki/smith-and-nephew-medical · Editorial policy · How profiles are compiled